The Feasibility and Impact of Implementing Interventions to Reduce Short-Acting &#x3b2;(2)-Agonist Over-Reliance in Asthma: An Expert Opinion

Asthma

Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Initiation in Japanese Patients with Asthma Previously on Inhaled Corticosteroid/Long-Acting β(2)-Agonist Therapy: A Retrospective Cohort Study

J Clin Med

Oga T, Gon Y, Takano M, Ito R, Mita C, Mukai I, Noorduyn SG, Requena G, Yarita M

doi: 10.3390/jcm14082566

COPD

Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS

Respir Res

Singh D, Bafadhel M, Arya N, Marshall J, Parikh H, Kisielewicz D, Movitz C, Bowen K, Patel M

doi: 10.1186/s12931-025-03234-5

Asthma

Impact of Health Insurance Type on Access to Biologics and Systemic Corticosteroid Exposure in Patients With Severe Asthma: A Real-World Study From the Korean Severe Asthma Registry (KoSAR)

Allergy Asthma Immunol Res

Sohn KH, Lee SK, Lee HY, Kim SR, Lee SE, Kim JH, Song WJ, Kim SH, Korean Severe Asthma Registry (KoSAR) Investigators

doi: 10.4168/aair.2026.18.2.192

Asthma

Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study

J Asthma Allergy

Adrish M, DeMartino JK, Carstens D, Jackson M, Schinkel J, Wilson K, Tkacz J

doi: 10.2147/JAA.S568990

Asthma

Adherence to Biologic Therapies is Associated with Improved Clinical Outcomes and Reduced Healthcare Resource Utilization in Patients with Severe Asthma in Japan

J Asthma Allergy

Nagase H, Karsanji U, Kunishige H, Suzuki T, Vichiendilokkul A, Yuanita L, Sasakura N, Wang J, Noibi S

doi: 10.2147/JAA.S590261

Asthma

Real-World Response to Dupilumab as Add-on Therapy in Adults and Adolescents with Type 2 Severe Asthma: A Spanish Cohort Study

J Asthma Allergy

Montoro Ferrer A, Moro Moro MDM, Parra Borreguero FM, Moreno-Ancillo A, Extremera Ortega AM, Galindo-Bonilla PA, Jiménez Lara M, Bravo Nieto JM, Jiménez Arroyo M, Lemus Calderón JA, Espinosa de Los Monteros Garde MJ

doi: 10.2147/JAA.S582686

Asthma

Prescriber adherence to asthma treatment guidelines and its impact on symptom control in Ethiopia: a mixed-methods study

Ther Adv Respir Dis

Assefa AN, Alemu MA, Tadesse TY, Aklog AT, Tarekegn GY, Moges TA, Dagnew SB

doi: 10.1177/17534666261436694

Asthma

Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 study

Lancet Respir Med

Maspero JF, Pavord ID, Wechsler ME, Busse W, Laidlaw TM, Mróz RM, Liu T, Mikol V, Suratt BT, Gereige J, Mannent L, Martincova R

doi: 10.1016/S2213-2600(25)00439-4

Asthma

Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma

Nat Commun

Gaberino CL, Segnitz RM, Dill-McFarland KA, Bacharier LB, Calatroni A, Gill MA, Stokes J, Liu AH, Cohen RT, Kumar R, Lang A, Khurana Hershey GK, Sherenian MG, Zoratti EM, Teach SJ, Kattan M, Becker PM, Togias A, Busse WW, Jackson DJ, Altman MC

doi: 10.1038/s41467-025-63629-2

Pneumology

The Feasibility and Impact of Implementing Interventions to Reduce Short-Acting β(2)-Agonist Over-Reliance in Asthma: An Expert Opinion

Related content

Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Initiation in Japanese Patients with Asthma Previously on Inhaled Corticosteroid/Long-Acting β(2)-Agonist Therapy: A Retrospective Cohort Study

Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS

Impact of Health Insurance Type on Access to Biologics and Systemic Corticosteroid Exposure in Patients With Severe Asthma: A Real-World Study From the Korean Severe Asthma Registry (KoSAR)

Benralizumab Reduces Asthma Exacerbations and Costs Among Medicare Beneficiaries with Severe Asthma: The ZEPHYR-5 Study

Adherence to Biologic Therapies is Associated with Improved Clinical Outcomes and Reduced Healthcare Resource Utilization in Patients with Severe Asthma in Japan

Real-World Response to Dupilumab as Add-on Therapy in Adults and Adolescents with Type 2 Severe Asthma: A Spanish Cohort Study

Prescriber adherence to asthma treatment guidelines and its impact on symptom control in Ethiopia: a mixed-methods study

Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 study

Mepolizumab alters gene regulatory networks of nasal airway type-2 and epithelial inflammation in urban children with asthma